{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:51:11Z","timestamp":1773251471065,"version":"3.50.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P35241"],"award-info":[{"award-number":["P35241"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118285","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T22:16:28Z","timestamp":1760998588000},"page":"118285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Identification of a novel PDE4 inhibitor inspired by leoligin-derived lignans"],"prefix":"10.1016","volume":"302","author":[{"given":"Christine","family":"Coffey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3922-6333","authenticated-orcid":false,"given":"Alexander F.","family":"Perhal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wito","family":"Richter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Linder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Schwaiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marko D.","family":"Mihovilovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Kirchmair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Schn\u00fcrch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Verena M.","family":"Dirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejmech.2025.118285_bib1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/hlca.200390072","article-title":"New Lignan, benzofuran, and sesquiterpene derivatives from the roots of Leontopodium alpinum and L. leontopodioides","volume":"86","author":"Dobner","year":"2003","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/j.ejmech.2025.118285_bib2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.fitote.2014.06.008","article-title":"Lignan formation in hairy root cultures of Edelweiss (Leontopodium nivale ssp. alpinum (Cass.) Greuter)","volume":"97","author":"Wawrosch","year":"2014","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ejmech.2025.118285_bib3","series-title":"Synthetic lignans targeting cardiovascular diseases [Doctoral dissertation]","author":"Linder","year":"2016"},{"issue":"22","key":"10.1016\/j.ejmech.2025.118285_bib4","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1039\/C9SC00446G","article-title":"Leoligin-inspired synthetic lignans with selectivity for cell-type and bioactivity relevant for cardiovascular disease","volume":"10","author":"Linder","year":"2019","journal-title":"Chem. Sci."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118285_bib5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.atherosclerosis.2011.07.023","article-title":"Leoligin, the major lignan from Edelweiss, activates cholesteryl ester transfer protein","volume":"219","author":"Duwensee","year":"2011","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.ejmech.2025.118285_bib6","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1021\/acs.jnatprod.6b00227","article-title":"Leoligin, the major lignan from Edelweiss (Leontopodium nivale subsp. alpinum), promotes cholesterol efflux from THP-1 macrophages","volume":"79","author":"Wang","year":"2016","journal-title":"J. Nat. Prod."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118285_bib7","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/cvr\/cvp059","article-title":"Leoligin, the major lignan from Edelweiss, inhibits intimal hyperplasia of venous bypass grafts","volume":"82","author":"Reisinger","year":"2009","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118285_bib8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/biomedicines10010062","article-title":"Investigation of leoligin derivatives as NF-\u03ba\u0392 inhibitory agents","volume":"10","author":"Linder","year":"2022","journal-title":"Biomedicines"},{"issue":"15","key":"10.1016\/j.ejmech.2025.118285_bib9","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1055\/a-1171-8357","article-title":"Characterization of a structural leoligin analog as Farnesoid X receptor agonist and modulator of cholesterol transport","volume":"86","author":"Ladurner","year":"2020","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2025.118285_bib10","series-title":"Uses of Tetrahydrofuran-type Lignans. CN 116650468 A","author":"Li","year":"2023"},{"issue":"15","key":"10.1016\/j.ejmech.2025.118285_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25158052","article-title":"PDE4D: a multipurpose pharmacological target","volume":"25","author":"Lusardi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118285_bib12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cyto.2009.11.005","article-title":"A review of the herbal phosphodiesterase inhibitors; future perspective of new drugs","volume":"49","author":"Rahimi","year":"2010","journal-title":"Cytokine"},{"issue":"13","key":"10.1016\/j.ejmech.2025.118285_bib13","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1016\/j.bmcl.2009.01.057","article-title":"Exploration and optimization of substituted triazolothiadiazines and triazolopyridazines as PDE4 inhibitors","volume":"19","author":"Skoumbourdis","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"16","key":"10.1016\/j.ejmech.2025.118285_bib14","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1021\/jm010837k","article-title":"Novel selective PDE4 inhibitors. 1. Synthesis, structure\u2212activity relationships, and molecular modeling of 4-(3,4-dimethoxyphenyl)-2H-phthalazin-1-ones and analogues","volume":"44","author":"Van der Mey","year":"2001","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2025.118285_bib15","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrm911","article-title":"Cyclic nucleotide research\u2014still expanding after half a century","volume":"3","author":"Beavo","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118285_bib16","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1152\/physrev.00030.2010","article-title":"Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions","volume":"91","author":"Francis","year":"2011","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118285_bib17","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1152\/physrev.1995.75.4.725","article-title":"Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms","volume":"75","author":"Beavo","year":"1995","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejmech.2025.118285_bib18","doi-asserted-by":"crossref","DOI":"10.1177\/1753465812466167","article-title":"Efficacy and safety of roflumilast in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"7","author":"Oba","year":"2013","journal-title":"Ther. Adv. Respir. Dis."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118285_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s40257-017-0302-0","article-title":"Apremilast: a novel oral treatment for psoriasis and psoriatic arthritis","volume":"19","author":"Torres","year":"2018","journal-title":"Am. J. Clin. Dermatol."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118285_bib20","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/8755122519844507","article-title":"Crisaborole: a novel nonsteroidal topical treatment for atopic dermatitis","volume":"35","author":"McDowell","year":"2019","journal-title":"J. Pharm. Technol."},{"issue":"12","key":"10.1016\/j.ejmech.2025.118285_bib21","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.tips.2019.10.006","article-title":"Phosphodiesterase type 4 inhibition in CNS diseases","volume":"40","author":"Blokland","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2025.118285_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135281","article-title":"Roflumilast: a potential drug for the treatment of cognitive impairment?","volume":"736","author":"Sugin","year":"2020","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118285_bib23","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/brain\/awac136","article-title":"Repurposing ibudilast to mitigate Alzheimer's disease by targeting inflammation","volume":"146","author":"Oliveros","year":"2022","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.ejmech.2025.118285_bib24","article-title":"Synergy between 5-HT(4) receptor stimulation and phosphodiesterase 4 inhibition in facilitating acetylcholine release in human large intestinal circular muscle","volume":"30","author":"Pauwelyn","year":"2018","journal-title":"Neuro Gastroenterol. Motil."},{"issue":"9","key":"10.1016\/j.ejmech.2025.118285_bib25","doi-asserted-by":"crossref","first-page":"12533","DOI":"10.1096\/fj.202001016RR","article-title":"PAN-selective inhibition of cAMP-phosphodiesterase 4 (PDE4) induces gastroparesis in mice","volume":"34","author":"McDonough","year":"2020","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118285_bib26","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1021\/jm9505066","article-title":"Biarylcarboxylic acids and -amides: inhibition of phosphodiesterase type IV versus [3H]rolipram binding activity and their relationship to emetic behavior in the ferret","volume":"39","author":"Duplantier","year":"1996","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118285_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nbt.1598","article-title":"Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety","volume":"28","author":"Burgin","year":"2010","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118285_bib28","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cellsig.2013.12.003","article-title":"Structural basis for the design of selective phosphodiesterase 4B inhibitors","volume":"26","author":"Fox","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejmech.2025.118285_bib29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-3-642-17969-3_7","article-title":"Small molecule allosteric modulators of phosphodiesterase 4","volume":"204","author":"Gurney","year":"2011","journal-title":"Handb. Exp. Pharmacol."},{"issue":"12","key":"10.1016\/j.ejmech.2025.118285_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/biology10121355","article-title":"Assessment of PDE4 inhibitor-induced hypothermia as a correlate of nausea in mice","volume":"10","author":"Boyd","year":"2021","journal-title":"Biology"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118285_bib31","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1523\/JNEUROSCI.5236-10.2011","article-title":"Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling","volume":"31","author":"Li","year":"2011","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118285_bib32","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1460-9568.2008.06349.x","article-title":"Enhanced long-term potentiation and impaired learning in phosphodiesterase 4D-knockout (PDE4D) mice","volume":"28","author":"Rutten","year":"2008","journal-title":"Eur. J. Neurosci."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118285_bib33","first-page":"587","article-title":"Antidepressant-like profile and reduced sensitivity to rolipram in mice deficient in the PDE4D phosphodiesterase enzyme","volume":"27","author":"Zhang","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.ejmech.2025.118285_bib34","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1038\/s41386-018-0178-6","article-title":"Memory enhancing effects of BPN14770, an allosteric inhibitor of phosphodiesterase-4D, in wild-type and humanized mice","volume":"43","author":"Zhang","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.ejmech.2025.118285_bib35","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/sj.bjp.0704743","article-title":"Long PDE4 cAMP-specific phosphodiesterases are activated by protein kinase A-mediated phosphorylation of a single serine residue in upstream conserved region 1 (UCR1)","volume":"136","author":"MacKenzie","year":"2002","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.ejmech.2025.118285_bib36","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1093\/emboj\/20.8.1921","article-title":"mAKAP assembles a protein kinase A\/PDE4 phosphodiesterase cAMP signaling module","volume":"20","author":"Dodge","year":"2001","journal-title":"EMBO J."},{"issue":"8","key":"10.1016\/j.ejmech.2025.118285_bib37","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35085068","article-title":"Transcriptional regulation by the phosphorylation-dependent factor CREB","volume":"2","author":"Mayr","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.ejmech.2025.118285_bib38","doi-asserted-by":"crossref","first-page":"399","DOI":"10.14348\/molcells.2023.2193","article-title":"The pleiotropic face of CREB family transcription factors","volume":"46","author":"Chowdhury","year":"2023","journal-title":"Mol. Cells"},{"issue":"11","key":"10.1016\/j.ejmech.2025.118285_bib39","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.4049\/jimmunol.1001829","article-title":"The role of the transcription factor CREB in immune function","volume":"185","author":"Wen","year":"2010","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.ejmech.2025.118285_bib40","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1074\/jbc.M207448200","article-title":"cAMP-induced interleukin-10 promoter activation depends on CCAAT\/enhancer-binding protein expression and monocytic differentiation","volume":"278","author":"Brenner","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"34","key":"10.1016\/j.ejmech.2025.118285_bib41","doi-asserted-by":"crossref","first-page":"20828","DOI":"10.1074\/jbc.271.34.20828","article-title":"Elevated cyclic AMP inhibits NF-\u03baB-mediated transcription in human monocytic cells and endothelial cells","volume":"271","author":"Ollivier","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"23","key":"10.1016\/j.ejmech.2025.118285_bib42","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1007\/s00018-011-0757-8","article-title":"Cyclic AMP: a selective modulator of NF-\u03baB action","volume":"68","author":"Gerlo","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"issue":"9","key":"10.1016\/j.ejmech.2025.118285_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024392","article-title":"Cyclic AMP control measured in two compartments in HEK293 cells: phosphodiesterase K(M) is more important than phosphodiesterase localization","volume":"6","author":"Matthiesen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.118285_bib44","series-title":"Elucidation of signal transduction mechanisms with pathological relevance for cardiovascular diseases in vitro and in vivo [Doctoral dissertation]","author":"Perhal","year":"2020"},{"issue":"3","key":"10.1016\/j.ejmech.2025.118285_bib45","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.4049\/jimmunol.175.3.1523","article-title":"Specific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophages","volume":"175","author":"Jin","year":"2005","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118285_bib46","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/sj.bjp.0701124","article-title":"In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor-\u03b1 release by PDE inhibitors","volume":"121","author":"Gantner","year":"1997","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118285_bib47","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1006\/bbrc.2001.6259","article-title":"Cyclic AMP-specific phosphodiesterase 4 inhibitors promote ABCA1 expression and cholesterol efflux","volume":"290","author":"Lin","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"43","key":"10.1016\/j.ejmech.2025.118285_bib48","doi-asserted-by":"crossref","first-page":"40212","DOI":"10.1074\/jbc.M203585200","article-title":"Dimerization of the type 4 cAMP-specific phosphodiesterases is mediated by the upstream conserved regions (UCRs)","volume":"277","author":"Richter","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2025.118285_bib49","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1042\/BCJ20210212","article-title":"The cAMP-phosphodiesterase 4 (PDE4) controls \u03b2-adrenoceptor- and CFTR-dependent saliva secretion in mice","volume":"478","author":"Boyd","year":"2021","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118285_bib50","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-\u0394\u0394CT) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.ejmech.2025.118285_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.935692","article-title":"Sulforaphane diminishes moonlighting of pyruvate kinase M2 and interleukin-1\u03b2 expression in M1 (LPS) macrophages","volume":"13","author":"Bahiraii","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2025.118285_bib52","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/cber.187901201117","article-title":"Bemerkungen zu der Abhandlung der HH. Weselky und Benedikt \u201cUeber einige Azoverbindungen\u201d","volume":"12","author":"Griess","year":"2006","journal-title":"Ber. Dtsch. Chem. Ges."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118285_bib53","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2025.118285_bib54","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jare.2021.02.006","article-title":"Identification of phosphodiesterase-4 as the therapeutic target of arctigenin in alleviating psoriatic skin inflammation","volume":"33","author":"Li","year":"2021","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ejmech.2025.118285_bib55","series-title":"Rdkit. Version 2022.09.05","year":"2022"},{"key":"10.1016\/j.ejmech.2025.118285_bib56","series-title":"Ligprep, Version 2024-2","year":"2024"},{"issue":"12","key":"10.1016\/j.ejmech.2025.118285_bib57","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: a software program for pKa prediction and protonation state generation for drug-like molecules","volume":"21","author":"Shelley","year":"2007","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"7","key":"10.1016\/j.ejmech.2025.118285_bib58","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: improving force field accuracy on challenging regimes of chemical space","volume":"17","author":"Lu","year":"2021","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.ejmech.2025.118285_bib59","series-title":"Protein Preparation Wizard; Epik, Version 2024-2","year":"2024"},{"issue":"3","key":"10.1016\/j.ejmech.2025.118285_bib60","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2025.118285_bib61","series-title":"Induced Fit Docking Protocol; Glide; Prime, Version 2024-2","year":"2024"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425010505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425010505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T22:27:11Z","timestamp":1773181631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425010505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":61,"alternative-id":["S0223523425010505"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118285","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of a novel PDE4 inhibitor inspired by leoligin-derived lignans","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118285","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118285"}}